Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)

View source ↗

Summary

FDA approved a supplemental application for ANDROGEL (testosterone) submitted by ASCEND Therapeutics U.S., LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANDROGEL (Testosterone)

Snippet

SUPPL AP for ANDROGEL (TESTOSTERONE)